pep005 has been researched along with Porokeratosis* in 2 studies
2 other study(ies) available for pep005 and Porokeratosis
| Article | Year |
|---|---|
Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.
Disseminated superficial actinic porokeratosis (DSAP) is a chronic condition characterized by numerous atrophic papules and patches with a distinctive peripheral keratotic ridge, typically found on sun-exposed areas. Treatment of DSAP is warranted not only for cosmetic and symptomatic benefits but also to prevent malignant transformation. Successful treatment of DSAP often is difficult and frequently requires the use of multiple modalities. Ingenol mebutate gel 0.05% is a topical medication primarily used for the treatment of actinic keratosis (AK) by inducing cell death. We report a case of DSAP treated effectively with ingenol mebutate gel 0.05%. Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Diterpenes; Female; Gels; Humans; Porokeratosis; Treatment Outcome | 2017 |
Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option.
Topics: Dermatologic Agents; Diterpenes; Female; Follow-Up Studies; Humans; Middle Aged; Porokeratosis; Treatment Outcome | 2015 |